Epilepsy Genetics tests in Dubai & UAE

Compare available Epilepsy Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Epilepsy Genetics test prices

Showing 1–10 of 10 matching tests.

Epilepsy Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4346 CPA6 Gene Familial Temporal Lobe Epilepsy Type 5 Genetic Testing Test This test evaluates the CPA6 gene for pathogenic variants associated with autosomal dominant familial temporal lobe epilepsy type 5 (FTLE5). It uses Next-Generation Sequencing (NGS...	Whole Blood (EDTA), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CPA6 gene", "Coding exons and flanking intronic regions of CPA6"] Parameters [] Preparation ["No fasting required", "Continue regular medications unless advised otherwise by physician", "Avoid heavy physical exertion immediately before blood draw"] Indications ["Suspected diagnosis of Familial Temporal Lobe Epilepsy Type 5 (FTLE5)", "Cascade screening of family members with a known CPA6 mutation", "Personalized antiepileptic therapy selection"] Measurement technique Confirm with laboratory Codes LOINC: 81261-7 ICD-10: G40.2 Clinical summary This test evaluates the CPA6 gene for pathogenic variants associated with autosomal dominant familial temporal lobe epilepsy type 5 (FTLE5). It uses Next-Generation Sequencing (NGS) and Sanger confirmation to detect mutations.
TEST-4344 CUX2 Gene-Related Early Infantile Epileptic Encephalopathy Type 67 (EIEE67) Test This test identifies pathogenic variants in the CUX2 gene associated with early infantile epileptic encephalopathy type 67 (EIEE67).	Peripheral whole blood, dried blood spot (FTA card) or extracted DNA	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CUX2 gene variants", "Pathogenic mutations"] Parameters [] Preparation ["Continue all medications", "Provide comprehensive clinical history", "Fasting is not required"] Indications ["Suspected EIEE67", "Neonatal-onset seizures", "Developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 90637-3 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants in the CUX2 gene associated with early infantile epileptic encephalopathy type 67 (EIEE67).
TEST-4401 GABRA1 Genetic Susceptibility Testing for Childhood Absence Epilepsy Type 4 (NGS) Test This test evaluates the GABRA1 gene for pathogenic variants associated with childhood absence epilepsy type 4.	Peripheral blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GABRA1 gene sequence", "Pathogenic variants in GABRA1"] Parameters [] Preparation [] Indications ["Diagnosis of childhood absence epilepsy type 4", "Family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: G40.A0 Clinical summary This test evaluates the GABRA1 gene for pathogenic variants associated with childhood absence epilepsy type 4.
TEST-4295 GNAO1 Gene Early Infantile Epileptic Encephalopathy Type 17 (EIEE17) Genetic Test This test identifies pathogenic variants within the GNAO1 gene associated with early infantile epileptic encephalopathy type 17 (EIEE17).	Peripheral whole blood or capillary blood (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GNAO1 gene coding region variants", "Pathogenic variants causing EIEE17"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any heparin therapy"] Indications ["Suspected diagnosis of Early Infantile Epileptic Encephalopathy Type 17 (EIEE17)", "Infants with refractory seizures and developmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 82317-9 ICD-10: G40.4 Clinical summary This test identifies pathogenic variants within the GNAO1 gene associated with early infantile epileptic encephalopathy type 17 (EIEE17).
TEST-4259 GRIN2B Gene Sequencing for Early Infantile Epileptic Encephalopathy Type 27 (Genetic Test) This test evaluates the GRIN2B gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 27 (EIEE27).	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["GRIN2B gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Suspected Early Infantile Epileptic Encephalopathy Type 27 (EIEE27)", "Refractory seizures in infancy", "Neurodevelopmental delay"] Measurement technique Confirm with laboratory Codes LOINC: 10367-2 ICD-10: G40.4 Clinical summary This test evaluates the GRIN2B gene for pathogenic variants associated with Early Infantile Epileptic Encephalopathy Type 27 (EIEE27).
TEST-4422 HCN2 Gene Epilepsy Genetic Test This test screens for pathogenic variants in the HCN2 gene associated with certain types of epilepsy.	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the HCN2 gene", "Single nucleotide variants", "Small insertions and deletions", "Copy number variations"] Parameters [] Preparation ["Mandatory genetic counselling session prior to testing"] Indications ["Clinical suspicion of genetic epilepsy", "Early-onset epileptic encephalopathies", "Genetic generalized epilepsy syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 94646-6 ICD-10: G40.89 Clinical summary This test screens for pathogenic variants in the HCN2 gene associated with certain types of epilepsy.
TEST-4304 NECAP1 Gene Early Infantile Epileptic Encephalopathy Type 21 Genetic Test This test detects pathogenic variants within the NECAP1 gene associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21).	Peripheral Blood or Heel-stick (Infants)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NECAP1 gene sequence", "Pathogenic variants (mutations)"] Parameters [] Preparation ["No specific patient preparation is required."] Indications ["Infants presenting with symptoms suggestive of EIEE21", "Family history of EIEE21"] Measurement technique Confirm with laboratory Codes LOINC: 83464-2 ICD-10: G40.4 Clinical summary This test detects pathogenic variants within the NECAP1 gene associated with Early Infantile Epileptic Encephalopathy Type 21 (EIEE21).
TEST-4417 RELN Gene Epilepsy, Familial Temporal Lobe Type 7 Genetic Test This test evaluates the coding region of the RELN gene for pathogenic variants associated with autosomal dominant familial temporal lobe epilepsy type 7.	Peripheral whole blood (venous) or dried blood spot (FTA card)	3-4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the RELN gene", "Coverage uniformity across exons"] Parameters [] Preparation [] Indications ["Suspected familial temporal lobe epilepsy type 7", "Personal or family history suggestive of RELN-related epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 94863-0 ICD-10: G40.0 Clinical summary This test evaluates the coding region of the RELN gene for pathogenic variants associated with autosomal dominant familial temporal lobe epilepsy type 7.
TEST-4350 SCN3A Gene Focal Epilepsy Genetic Test (NGS) This test evaluates the SCN3A gene for pathogenic variants associated with focal epilepsy syndromes.	Whole Blood (EDTA), Saliva (Oragene DNA), or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SCN3A gene coding exons", "SCN3A gene splice sites", "SCN3A gene deep intronic regions", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [{"name": "Genomic Coverage", "reference_range": ">99% of coding exons, splice sites, and selected deep intronic regions"}] Preparation ["Do not discontinue any prescribed antiepileptic medication without direct consultation with your treating neurologist."] Indications ["Individuals presenting with unexplained focal seizures", "Early-onset epileptic encephalopathy", "Family history suggestive of autosomal dominant focal epilepsy"] Measurement technique Confirm with laboratory Codes LOINC: 95606-7 ICD-10: G40.109, G40.209 Clinical summary This test evaluates the SCN3A gene for pathogenic variants associated with focal epilepsy syndromes.
TEST-4429 SLC2A1 Gene Epilepsy (Idiopathic Generalized Type 12) Genetic Test This test evaluates the full coding sequence and exon-level copy number variations of the SLC2A1 gene to detect pathogenic variants associated with GLUT1 deficiency syndrome.	Whole Blood (EDTA) or Extracted Genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants (SNVs, indels) in the SLC2A1 gene", "Exon-level Copy Number Variations (CNVs) in the SLC2A1 gene"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any prescribed anti-epileptic drugs."] Indications ["Suspected Idiopathic Generalized Epilepsy Type 12 (GLUT1 deficiency syndrome)", "Patients with early-onset epilepsy and developmental delay", "Family history suggestive of GLUT1 deficiency syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 91634-4 ICD-10: G40.3 Clinical summary This test evaluates the full coding sequence and exon-level copy number variations of the SLC2A1 gene to detect pathogenic variants associated with GLUT1 deficiency syndrome.

Category overview

Epilepsy Genetics: overview

Understanding the broader hereditary factors associated with seizure disorders empowers families to access the most effective, proactive interventions and secure absolute reproductive confidence. Integrated into our comprehensive Genetics department, Epilepsy Genetics screening utilizes expansive panels to concurrently evaluate dozens of genes linked to structural, metabolic, and syndromic causes of epilepsy. By leveraging cutting-edge sequencing technology, this robust genomic profiling provides a complete molecular picture, safely guiding specialized pediatric neurology care, proactive metabolic interventions, and informed family planning decisions. Widely respected for complex neuro-diagnostic evaluations among the best diagnostic labs in Dubai and the UAE, DNA Labs guarantees strict patient confidentiality, exceptional diagnostic precision, and highly efficient reporting for sensitive cases. Empower your customized medical care journey—book your epilepsy genetics testing in UAE, arrange a secure clinical sample collection, or connect with our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.